| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA615195 | F | Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA619573 | F | Effective dose required for inhibitory activity against A549 human tumor cell line. | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 3. | ALA626815 | A | Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison. | 14 | assay format | Scientific Literature | |||
| 4. | ALA628546 | A | Statistical significance of IC 50 values; Expressed as R value | 14 | assay format | Scientific Literature | |||
| 5. | ALA652537 | F | Effective dose required for inhibitory activity against CAK1 human tumor cell line | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 6. | ALA689359 | F | Effective dose required for inhibitory activity against HCT-8 human tumor cell line. | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 7. | ALA687208 | F | Compound at 1 uM was tested in vitro to inhibit proliferation of HL-60 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 8. | ALA687209 | F | Compound at 10 uM was tested in vitro to inhibit proliferation of HL-60 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 9. | ALA687210 | F | Compound at 100 uM was tested in vitro to inhibit proliferation of HL-60 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 10. | ALA689326 | F | Effective dose required for inhibitory activity against HOS human tumor cell line. | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
| 11. | ALA702350 | F | Effective dose required for inhibitory activity against KB human tumor cell line. | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 12. | ALA704645 | F | Effective dose required for inhibitory activity against KB-VIN human tumor cell line. | Homo sapiens | 28 | cell-based format | Scientific Literature | ||
| 13. | ALA700216 | F | Compound at 1 uM was tested in vitro to inhibit proliferation of K562 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 14. | ALA700217 | F | Compound at 10 uM was tested in vitro to inhibit proliferation of K562 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 15. | ALA700218 | F | Compound at 100 uM was tested in vitro to inhibit proliferation of K562 leukemia cell line | Homo sapiens | 6 | cell-based format | Scientific Literature | ||
| 16. | ALA710192 | F | In vitro inhibitory activity was tested against L1210 leukemia cells | Mus musculus | 20 | cell-based format | Scientific Literature | ||
| 17. | ALA712001 | F | Effective dose required for inhibitory activity against MCF-7 human tumor cell line. | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
| 18. | ALA712027 | F | Cytotoxicity against MCF-7/Adr cells. | Homo sapiens | 17 | cell-based format | Scientific Literature | ||
| 19. | ALA747966 | B | Inhibition of NADH decylubiquinone (DB) oxidoreductase activity. | Bos taurus | 23 | assay format | Scientific Literature | ||
| 20. | ALA749246 | B | Inhibition of complex I activity was determined by NADH oxidase assay using bovine heart submitochondrial particles. | Bos taurus | 5 | protein complex format | Scientific Literature |
The page will load shortly, Thanks for your patience!